Privo Technologies is honored to receive a Phase 1 award for $220,000 from the NIDCR SBIR program to further develop its scale-up, chemistry, and manufacturing program.
Watch Dr. Goldberg's presentation below regarding localized treatment of cancers in a more safe and effective way and the positive results derived from preclinical studies.
The project was awarded over $300,000 in funding from MIT’s Deshpande Innovation Center in 2012 and 2013 to support the company’s drug development activities. We are proud to receive these very competitive awards and honored to be amongst some of...
- © UX Strategy & Digital Branding